POINT Biopharma Global Inc.
NASDAQ:PNT
12.5 (USD) • At close December 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -24.774 | -25.411 | -16.531 | 163.267 | -24.013 | -24.58 | -16.381 | -14.197 | -17.117 | -8.805 | -5.784 | -5.551 | -3.047 |
| Depreciation & Amortization
| 0.864 | 0.785 | 0.538 | 0.414 | 0.397 | 0.36 | 0.224 | 0.012 | 0 | 0 | 0 | 0 | 3.215 |
| Deferred Income Tax
| -1.454 | 0 | 0 | 1.452 | 0 | 0 | 0 | 0.003 | -0.101 | 0 | 0 | 0 | -0.074 |
| Stock Based Compensation
| 1.876 | 1.71 | 1.009 | 0.999 | 1.079 | 1.028 | 0.44 | 0.371 | 0.348 | 1.106 | 0.477 | 0.142 | 0.404 |
| Change In Working Capital
| -4.839 | -47.515 | -4.248 | 72.302 | 0.581 | 2.743 | 5.225 | 0.511 | 2.307 | 1.668 | -5.663 | 0.889 | 3.136 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| -5.346 | -3.459 | 7.745 | 3.564 | -3.029 | 0.37 | 3.92 | -1.644 | -1.421 | 3.958 | -2.915 | 1.639 | 1.686 |
| Other Working Capital
| 0.506 | -44.055 | -11.993 | 68.738 | 3.611 | 2.372 | 1.305 | 2.155 | 3.729 | -2.29 | -2.748 | -0.75 | 1.45 |
| Other Non Cash Items
| 0.196 | -3.906 | -3.16 | -1.518 | -0.373 | -0.128 | 0 | -0.012 | 0.006 | 0.167 | 0.003 | 0.003 | -3.212 |
| Operating Cash Flow
| -28.132 | -74.336 | -22.391 | 236.916 | -22.328 | -20.578 | -10.491 | -13.312 | -14.557 | -5.863 | -10.967 | -4.517 | 0.422 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -6.393 | -7.331 | -3.525 | -2.07 | -7.616 | -2.139 | -0.941 | -0.698 | -2.248 | -5.67 | -0.187 | -3.706 | -6.091 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -1.008 | 32.769 | -149.519 | -87.657 | -39.278 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | -5 | 0 | 0 | 0 | -126.563 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -7.401 | 20.437 | -153.043 | -89.727 | -46.895 | -128.702 | -0.941 | -0.698 | -2.248 | -5.67 | -0.187 | -3.706 | -6.091 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 13.45 | 116.856 | 0 | 0 | 20.544 | -0.544 | 0 | 0 | 4.714 | 25.426 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.152 | 0.052 | 0.146 | 13.456 | 116.898 | 0.003 | 0.001 | -20.544 | -4.107 | 265.427 | 20.45 | 132.387 | 17.393 |
| Financing Cash Flow
| -0.152 | 0.052 | 0.146 | 13.456 | 116.898 | 0.003 | 0.001 | 0 | -4.107 | 265.427 | 20.45 | 137.101 | 17.393 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.691 | -9.691 | -128.924 | -10.647 |
| Net Change In Cash
| -35.686 | -53.846 | -175.289 | 160.645 | 47.675 | -149.277 | -11.431 | -14.01 | -20.911 | 253.894 | 9.296 | -8.224 | 11.724 |
| Cash At End Of Period
| 21.607 | 57.293 | 111.14 | 286.428 | 125.783 | 78.108 | 227.385 | 238.816 | 252.826 | 273.737 | 19.843 | 10.547 | 18.77 |